Researchers at The University of Texas Health Science Center at San Antonio, also known as UT Health San Antonio, are asking for community input about participating in an international study.
Share This Story
Attention deficit hyperactivity disorder, or ADHD, can affect adults. Click here to learn how to identify the symptoms, when to seek medical care and possible treatment options in this article featured in the San Antonio Express-News’ San Antonio Life: Wellness section. The article is part of a wellness series developed through a collaboration between […]
Share This Story
An “artificial enamel” ingredient in toothpaste has been shown to help restore enamel in teeth, more effectively relieving sensitivity than fluoride while fighting cavities, according to an internationally published study led by a UT Health San Antonio School of Dentistry professor and researcher. The ingredient, a synthetic version of the natural mineral hydroxyapatite that […]
Share This Story
Artificial intelligence insulin delivery and glucose monitoring system cleared for age 6 and older While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared Friday, May 19, by the U.S. Food and Drug Administration, will relieve youth and their parents of constant worries over estimating insulin doses and […]
Share This Story
Each year, U.S. and Canadian academic health centers are invited to nominate faculty for this highly competitive program. UT Health San Antonio has a total of 13 faculty members who have successfully completed this prestigious fellowship program.
Share This Story
While there are many diets to choose from, there has been a recent upsurge in the keto, carb control and sugar control diets. Click here to learn more about these diets in this article featured in the San Antonio Express-News’ San Antonio Life: Wellness section. The article is part of a wellness series developed through a […]
Share This Story
Alicia S. Parker, MD, of The University of Texas Health Science Center at San Antonio, is assistant professor of cognitive and behavioral neurology and clinic director for the health science center’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. The Biggs Institute, in partnership with The University of Texas Rio Grande Valley, is Texas’ […]
Share This Story
An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said. The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM). The Mays Cancer Center, one of the four National Cancer […]
Share This Story
Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience therapy resistance leading to low long-term survival rates, with only 7.2% of patients surviving beyond […]
Share This Story
UT Health San Antonio President William L. Henrich, MD, MACP, was quoted in this article. Read Now
Share This Story